Summitry LLC Boosts Holdings in Procter & Gamble Company (The) $PG

Summitry LLC raised its holdings in shares of Procter & Gamble Company (The) (NYSE:PG) by 9.0% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 57,338 shares of the company’s stock after acquiring an additional 4,737 shares during the quarter. Summitry LLC’s holdings in Procter & Gamble were worth $8,217,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds have also recently added to or reduced their stakes in the business. Trilogy Capital Inc. increased its holdings in Procter & Gamble by 1.1% during the 4th quarter. Trilogy Capital Inc. now owns 6,289 shares of the company’s stock valued at $901,000 after acquiring an additional 67 shares in the last quarter. Lorne Steinberg Wealth Management Inc. increased its holdings in Procter & Gamble by 2.7% during the 4th quarter. Lorne Steinberg Wealth Management Inc. now owns 2,623 shares of the company’s stock valued at $376,000 after acquiring an additional 68 shares in the last quarter. Grant Street Asset Management Inc. increased its holdings in Procter & Gamble by 2.7% during the 4th quarter. Grant Street Asset Management Inc. now owns 2,627 shares of the company’s stock valued at $376,000 after acquiring an additional 69 shares in the last quarter. Beech Hill Advisors Inc. increased its holdings in Procter & Gamble by 0.5% during the 4th quarter. Beech Hill Advisors Inc. now owns 14,238 shares of the company’s stock valued at $2,040,000 after acquiring an additional 70 shares in the last quarter. Finally, Aull & Monroe Investment Management Corp boosted its stake in shares of Procter & Gamble by 0.3% during the 4th quarter. Aull & Monroe Investment Management Corp now owns 28,113 shares of the company’s stock worth $4,029,000 after purchasing an additional 71 shares during the last quarter. 65.77% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

PG has been the topic of several analyst reports. Jefferies Financial Group decreased their price target on shares of Procter & Gamble from $179.00 to $175.00 and set a “buy” rating on the stock in a research note on Monday, April 20th. Morgan Stanley decreased their price target on shares of Procter & Gamble from $175.00 to $166.00 and set an “overweight” rating on the stock in a research note on Wednesday, April 22nd. Deutsche Bank Aktiengesellschaft reaffirmed a “buy” rating and set a $163.00 price target on shares of Procter & Gamble in a research note on Monday, April 27th. Raymond James Financial decreased their price target on shares of Procter & Gamble from $175.00 to $170.00 and set an “outperform” rating on the stock in a research note on Tuesday, April 14th. Finally, Weiss Ratings reaffirmed a “hold (c)” rating on shares of Procter & Gamble in a research note on Friday, March 27th. Eleven equities research analysts have rated the stock with a Buy rating and nine have issued a Hold rating to the stock. According to MarketBeat, Procter & Gamble currently has a consensus rating of “Moderate Buy” and a consensus price target of $161.06.

Procter & Gamble Price Performance

PG opened at $144.50 on Tuesday. The company’s 50 day simple moving average is $144.82 and its 200 day simple moving average is $147.93. The company has a debt-to-equity ratio of 0.44, a quick ratio of 0.53 and a current ratio of 0.73. Procter & Gamble Company has a 1 year low of $137.62 and a 1 year high of $170.99. The stock has a market capitalization of $336.49 billion, a PE ratio of 21.13, a P/E/G ratio of 6.19 and a beta of 0.41.

Procter & Gamble (NYSE:PG) last released its earnings results on Friday, April 24th. The company reported $1.59 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.56 by $0.03. Procter & Gamble had a net margin of 19.16% and a return on equity of 32.00%. The business had revenue of $21.24 billion for the quarter, compared to analysts’ expectations of $21.52 billion. During the same period last year, the company earned $1.54 earnings per share. The company’s quarterly revenue was up 7.4% on a year-over-year basis. Procter & Gamble has set its FY 2026 guidance at 6.830-7.090 EPS. As a group, sell-side analysts expect that Procter & Gamble Company will post 6.91 EPS for the current year.

Procter & Gamble Increases Dividend

The business also recently announced a quarterly dividend, which was paid on Friday, May 15th. Investors of record on Friday, April 24th were given a $1.0885 dividend. This is a boost from Procter & Gamble’s previous quarterly dividend of $1.06. This represents a $4.35 annualized dividend and a dividend yield of 3.0%. The ex-dividend date of this dividend was Friday, April 24th. Procter & Gamble’s dividend payout ratio is 63.60%.

Insider Activity

In related news, CEO Ma. Fatima Francisco sold 5,549 shares of the firm’s stock in a transaction that occurred on Friday, February 27th. The shares were sold at an average price of $165.29, for a total value of $917,194.21. Following the sale, the chief executive officer directly owned 1,029 shares of the company’s stock, valued at approximately $170,083.41. This trade represents a 84.36% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Corporate insiders own 0.20% of the company’s stock.

Procter & Gamble Company Profile

Procter & Gamble (NYSE: PG) is a multinational consumer goods company headquartered in Cincinnati, Ohio. Founded in 1837 by William Procter and James Gamble, P&G has grown into one of the world’s largest producers of branded consumer packaged goods. The company focuses on developing, manufacturing and marketing a broad portfolio of household and personal care products sold to consumers and retailers worldwide.

P&G’s product offering spans several core business categories, including Beauty, Grooming, Health Care, Fabric & Home Care, and Baby, Feminine & Family Care.